F. SAYDAM Et Al. , "Impact of CYP2C19 Variants on the Antiplatelet Effect of Clopidogrel in Turkish Patients with Acute Coronary Syndrome," Erişkin yaşta görülen genetik hastalıklar sempozyumu , İstanbul, Turkey, pp.28, 2013
SAYDAM, F. Et Al. 2013. Impact of CYP2C19 Variants on the Antiplatelet Effect of Clopidogrel in Turkish Patients with Acute Coronary Syndrome. Erişkin yaşta görülen genetik hastalıklar sempozyumu , (İstanbul, Turkey), 28.
SAYDAM, F., DEĞİRMENCİ, İ., BİRDANE, A., ULUS, T., ÖZBAYER, C., ÖZDEMİR, M., ... BAL, C.(2013). Impact of CYP2C19 Variants on the Antiplatelet Effect of Clopidogrel in Turkish Patients with Acute Coronary Syndrome . Erişkin yaşta görülen genetik hastalıklar sempozyumu (pp.28). İstanbul, Turkey
SAYDAM, FARUK Et Al. "Impact of CYP2C19 Variants on the Antiplatelet Effect of Clopidogrel in Turkish Patients with Acute Coronary Syndrome," Erişkin yaşta görülen genetik hastalıklar sempozyumu, İstanbul, Turkey, 2013
SAYDAM, FARUK Et Al. "Impact of CYP2C19 Variants on the Antiplatelet Effect of Clopidogrel in Turkish Patients with Acute Coronary Syndrome." Erişkin yaşta görülen genetik hastalıklar sempozyumu , İstanbul, Turkey, pp.28, 2013
SAYDAM, F. Et Al. (2013) . "Impact of CYP2C19 Variants on the Antiplatelet Effect of Clopidogrel in Turkish Patients with Acute Coronary Syndrome." Erişkin yaşta görülen genetik hastalıklar sempozyumu , İstanbul, Turkey, p.28.
@conferencepaper{conferencepaper, author={FARUK SAYDAM Et Al. }, title={Impact of CYP2C19 Variants on the Antiplatelet Effect of Clopidogrel in Turkish Patients with Acute Coronary Syndrome}, congress name={Erişkin yaşta görülen genetik hastalıklar sempozyumu}, city={İstanbul}, country={Turkey}, year={2013}, pages={28} }